SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-047181
Filing Date
2020-10-22
Accepted
2020-10-22 09:11:47
Documents
5
Period of Report
2020-10-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K achv-8k_20201020.htm 8-K 28770
2 EX-99.1 achv-ex991_16.htm EX-99.1 24759
3 GRAPHIC g0ep5evosdkj000005.jpg GRAPHIC 3124
4 GRAPHIC g0ep5evosdkj000006.jpg GRAPHIC 1615
5 GRAPHIC g0ep5evosdkj000001.jpg GRAPHIC 10475
  Complete submission text file 0001564590-20-047181.txt   76287
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 201251855
SIC: 2835 In Vitro & In Vivo Diagnostic Substances